Akso Health Group (AHG)

Akso Health Group Cash Flow Statement

Financials in millions USD. Fiscal year is April - March.

Year Ending	TTM	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019
Net Income	-5.63	-1.36	-16.85	-34.83	-71.2	5.53
Depreciation & Amortization	-	0	0	0	0.12	0.02
Share-Based Compensation	-	0	0.39	0.06	0.35	6.59
Other Operating Activities	3.95	-1.89	7.83	44.83	12.45	-13.87
Operating Cash Flow	-1.68	-3.25	-8.63	10.06	-58.28	-1.73
Capital Expenditures	0	0	0	0	-0.19	-0
Change in Investments	0	18.47	-20	0	17.57	-67.1
Other Investing Activities	20	-	0.04	-0	-4.6	-1
Investing Cash Flow	20	18.47	-19.96	-0	12.78	-68.11
Dividends Paid	-	0	0	0	0	-19.55
Share Issuance / Repurchase	-	0	10.02	0	-2.39	-0.16
Debt Issued / Paid	-	-27.51	-10	-10	0	71.42
Other Financing Activities	0.35	-	34.76	0.96	0.83	-51.74
Financing Cash Flow	0.35	-27.51	34.78	-9.04	-1.55	-0.03
Exchange Rate Effect	2.84	-0.44	0.61	3.18	0.61	-5.38
Net Cash Flow	1.51	-12.73	6.8	4.2	-46.45	-75.25
Free Cash Flow	-1.68	-3.25	-8.63	10.06	-58.47	-1.73
Free Cash Flow Margin	-76.13%	-24.68%	-143.81%	-	-845.64%	-46.89%
Free Cash Flow Per Share	-0.07	-0.14	-0.43	0.62	-3.60	-0.11

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).